Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age
Clinical trial NCT03108625 · COMPLETED
Trial details
- NCT number
- NCT03108625
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2020-04-16
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.